| Identification | Back Directory | [Name]
2(1H)-QUINOLINONE, 5-[3-[(1,1-DIMETHYLETHYL)AMINO]-2-HYDROXYPROPOXY]-3,4-DIHYDRO-, MONOHYDROCHLORIDE | [CAS]
51781-21-6 | [Synonyms]
endak
oc1085
opc1085
mikelan
Carteol
Cartrol
Tenalet
Teoptic
Cartelo
Cartelol
Orukalol
Ocupress
Optipress
Arteoptic
Caltidren
endakmite
carbonolol
NSC 300906
Carteolol T
abbott-43326
carteolol HCl
carteololhydrochloride
dl-Carteolol hydrochloride
Carteolol monohydrochloride
Carteolol Hydrochloride (200 mg)
5-(2-hydroxy-3-tert-butylamino)propoxy-3,4-dihydrocarbostyrilhydrochloride
5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyrilhydrochloride
5-(3-tert-butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1h)-chinolinon-hydroch
5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-2(1h)-quinolin
5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone monohydrochloride
5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone Hydrochloride
5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone,hydrochloride (1:1)
2(1H)-Quinolinone,5-[3-[(1,1-diMethylethyl)aMino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride(1:1)
2(1H)-QUINOLINONE, 5-[3-[(1,1-DIMETHYLETHYL)AMINO]-2-HYDROXYPROPOXY]-3,4-DIHYDRO-, MONOHYDROCHLORIDE | [EINECS(EC#)]
257-415-7 | [Molecular Formula]
C16H25ClN2O3 | [MDL Number]
MFCD00941499 | [MOL File]
51781-21-6.mol | [Molecular Weight]
328.83 |
| Chemical Properties | Back Directory | [Appearance]
Crystalline Solid | [Melting point ]
278°C | [storage temp. ]
Refrigerator | [solubility ]
Soluble in water, sparingly soluble in methanol, slightly soluble in ethanol 96 per cent, practically insoluble in methylene chloride. | [form ]
neat | [color ]
White to Off-White | [Merck ]
14,1866 |
| Hazard Information | Back Directory | [Chemical Properties]
Crystalline Solid | [Uses]
-Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic; antiglaucoma | [Uses]
beta-adrenergic blocker | [Uses]
β-Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic; antiglaucoma. | [Brand name]
Cartrol (Abbott); Ocupress (Novartis). | [Biological Activity]
beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. β-blockers can also be used to treat migraine headache and increased eye pressure (glaucoma). carteolol is a nonselective beta-adrenoceptor antagonist. | [in vitro]
previous findings demonstrate that carteolol, unlike xamoterol, is a nonconventional partial agonist, which causes agonistic effects via interaction with the low-affinity propranolol-resistant site of β1-adrenoceptors and antagonistic actions by the high-affinity site of the same receptors [1]. | [in vivo]
both 8-oh carteolol and carteolol suppressed the water-load induced intraocular pressure (iop) rise in rabbits. 8-oh carteolol was more effective in suppressing water-load induced iop rise in rabbits compared with carteolol on equimolar basis. both 8-oh carteololand carteolol caused a significant decrease in iop in monkeys. 8-oh carteolol was estimated to be more potent than carteolol in lowering iop on equimolar basis in monkeys [2]. | [References]
[1] maura floreani, guglielmina froldi, luigi quintieri, katia varani, pier andrea borea, maria teresa dorigo and paola dorigo. in vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac β1-adrenoceptors: a comparison with xamoterol. jpet 315:1386–1395, 2005
[2] sugiyama k, enya t, kitazawa y. ocular hypotensive effect of 8-hydroxycarteolol, a metabolite of carteolol. int ophthalmol. 1989 jan;13(1-2):85-9.
[3] trinquand c, romanet jp, nordmann jp, allaire c; groupe d'étude. efficacy and safety of long-acting carteolol 1% once daily. a double-masked, randomized study. j fr ophtalmol. 2003 feb;26(2):131-6. |
| Safety Data | Back Directory | [RTECS ]
VC8282000 | [HS Code ]
2933790002 | [Toxicity]
LD50 in male mice, rats (mg/kg): 810, 1380 orally; 54.5, 158 i.v.; 380, 400 i.p. (Lang) |
|
|